I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Choudhury, Lubna
64
results:
Search for persons
X
Format
Online (64)
Mediatypes
Articles (Online) (43)
Bookchapter (Online) (1)
OpenAccess-fulltext (20)
Sorted by: Relevance
Sorted by: Year
?
1
Effect of Aficamten on Structure and Function in Patients w..:
Masri, Ahmad
;
Cardoso, Rhanderson
;
Abraham, Theodore
...
Journal of Cardiovascular Magnetic Resonance. 26 (2024) - p. 100772 , 2024
Link:
https://doi.org/10.1016/..
?
2
Safety and Efficacy of Metabolic Modulation With Ninerafaxs..:
Maron, Martin S.
;
Mahmod, Masliza
;
Abd Samat, Azlan Helmy
...
Journal of the American College of Cardiology. 83 (2024) 21 - p. 2037-2048 , 2024
Link:
https://doi.org/10.1016/..
?
3
Dosing and Safety Profile of Aficamten in Symptomatic Obstr..:
Coats, Caroline J.
;
Masri, Ahmad
;
Nassif, Michael E.
...
Journal of the American Heart Association. , 2024
Link:
https://doi.org/10.1161/..
?
4
Efficacy and Safety of Aficamten in Symptomatic Nonobstruct..:
MASRI, AHMAD
;
SHERRID, MARK V.
;
ABRAHAM, THEODORE P.
...
Journal of Cardiac Failure. , 2024
Link:
https://doi.org/10.1016/..
?
5
The Clinical Impact of SARS-CoV-2 on Hypertrophic Cardiomyo..:
Saleh, Danish
;
Meng, Zhiying
;
Johnson, Nicholas
...
Journal of Cardiovascular Development and Disease. 11 (2024) 4 - p. 104 , 2024
Link:
https://doi.org/10.3390/..
?
6
Reduction of Filamin C Results in Altered Proteostasis, Car..:
Ohiri, Joyce C.
;
Dellefave‐Castillo, Lisa
;
Tomar, Garima
...
Journal of the American Heart Association. 13 (2024) 10 - p. , 2024
Link:
https://doi.org/10.1161/..
?
7
Cumulative long-term efficacy and safety of mavacamten trea..:
Owens, Anjali
;
Sherrid, Mark
;
Rader, Florian
...
Journal of Cardiac Failure. 30 (2024) - p. S2-S3 , 2024
Link:
https://doi.org/10.1016/..
?
8
Long-term effect of mavacamten in obstructive hypertrophic ..:
Garcia-Pavia, Pablo
;
Oręziak, Artur
;
Masri, Ahmad
...
European Heart Journal. , 2024
Link:
https://doi.org/10.1093/..
?
9
Exercise Capacity in Patients With Obstructive Hypertrophic..:
Coats, Caroline J.
;
Maron, Martin S.
;
Abraham, Theodore P.
...
JACC: Heart Failure. 12 (2024) 1 - p. 199-215 , 2024
Link:
https://doi.org/10.1016/..
?
10
Baseline Characteristics of Patients in SEQUOIA-HCM: A Phas..:
Maron, Martin S.
;
Abraham, Theodore P.
;
Coats, Caroline J.
...
Journal of Cardiac Failure. 30 (2024) - p. S3 , 2024
Link:
https://doi.org/10.1016/..
?
11
Mavacamten Treatment for Symptomatic Obstructive Hypertroph..:
Rader, Florian
;
Oręziak, Artur
;
Choudhury, Lubna
...
JACC: Heart Failure. 12 (2024) 1 - p. 164-177 , 2024
Link:
https://doi.org/10.1016/..
?
12
Efficacy And Safety Of Aficamten In Patients With Symptomat..:
Masri, Ahmad
;
Abraham, Theodore P.
;
Choudhury, Lubna
...
Journal of Cardiac Failure. 29 (2023) 4 - p. 554 , 2023
Link:
https://doi.org/10.1016/..
?
13
Aficamten for Drug-Refractory Severe Obstructive Hypertroph..:
OWENS, ANJALI T.
;
MASRI, AHMAD
;
ABRAHAM, THEODORE P.
...
Journal of Cardiac Failure. 29 (2023) 11 - p. 1576-1582 , 2023
Link:
https://doi.org/10.1016/..
?
14
Phase 2 Study of Aficamten in Patients With Obstructive Hyp..:
Maron, Martin S.
;
Masri, Ahmad
;
Choudhury, Lubna
...
Journal of the American College of Cardiology. 81 (2023) 1 - p. 34-45 , 2023
Link:
https://doi.org/10.1016/..
?
15
Common genetic variants and modifiable risk factors underpi..:
Harper, Andrew R.
;
Goel, Anuj
;
Grace, Christopher
...
Nature Genetics. 53 (2021) 2 - p. 135-142 , 2021
Link:
https://doi.org/10.1038/..
1-15